ARCHIVES

Acting Commissioner Tells Grassley He Supports “Academic Freedom” at The Agency, but “At A Proper Time.”

This article is from The Cancer Letter archive.

Vol. 32 No. 43 | December 1, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Columiba Adds Presbyterian to Center’s Name: Clinton’s Mother Honored; DeVita move Rumored

March 5, 1993

U. S. Oncologists To Audit Another Bezwoda Trial.

November 10, 2000

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

January 12, 2007

NCAB Urges Reprogramming If Needed To Assure $150 Million For Construction Through FY 1985

June 8, 1979

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004